Open AccessHematopoietic cell transplantation for myeloid/ NK cell precursor acute leukemia in second remission
Author(s) -
Noguchi Yusuke,
Tomizawa Daisuke,
Hiroki Haruka,
Miyamoto Satoshi,
Tezuka Mari,
Miyawaki Reiji,
TanakaKubota Mari,
Okano Tubasa,
Kobayashi Chika,
Mitsuiki Noriko,
Aoki Yuki,
Imai Kohsuke,
Kajiwara Michiko,
Kanegane Hirokazu,
Morio Tomohiro,
Takagi Masatoshi
Publication year - 2018
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1506
Subject(s) - medicine , myeloid leukemia , leukemia , acute leukemia , myeloid , transplantation , precursor cell , immunology , haematopoiesis , hematopoietic stem cell transplantation , hematopoietic cell , cancer research , cell , stem cell , biology , genetics
Key Clinical Message Myeloid/natural killer cell precursor acute leukemia ( MNKPL ) is a rare leukemia subtype characterized by a high incidence of extramedullary infiltration. No appropriate treatment strategy has so far been developed. Acute myelogenous leukemia‐type chemotherapy combined with L‐Asparaginase is an effective treatment for MNKPL . Hematopoietic cell transplantation is a second option in refractory cases.